APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sufentanil (API)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Sufentanil (API) Market Outlook and Growth Opportunities 2026

21 December 2025190 pages

Choose your research edition.

Industry ResearchSufentanil (API) Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Sufentanil (API) Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Sufentanil (API) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sufentanil (API) Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Sufentanil (API) Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Sufentanil (API) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Sufentanil (API) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sufentanil (API) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sufentanil (API) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Sufentanil (API) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Sufentanil (API) market include Janssen Pharmaceuticals, Kern Pharma, Hameln Rds, Cristalia and Cambrex, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sufentanil (API) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sufentanil (API) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sufentanil (API) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sufentanil (API) market size, projected growth trends, production technologies, key applications, and end-use industries.

Sufentanil (API) Segment by Company

Janssen Pharmaceuticals

Kern Pharma

Hameln Rds

Cristalia

Cambrex

Sufentanil (API) Segment by Type

Purity 98%

Purity 99%

Sufentanil (API) Segment by Application

Injection

Capsule

Sufentanil (API) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Sufentanil (API) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Sufentanil (API) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Sufentanil (API) significant trends, drivers, influence factors in global and regions.

6. To analyze Sufentanil (API) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sufentanil (API) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sufentanil (API) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sufentanil (API).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sufentanil (API) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sufentanil (API) industry.

Chapter 3: Detailed analysis of Sufentanil (API) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Sufentanil (API) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Sufentanil (API) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Sufentanil (API) Industry Trends Table 2. Sufentanil (API) Industry Drivers Table 3. Sufentanil (API) Industry Opportunities and Challenges Table 4. Sufentanil (API) Industry Restraints Table 5. Global Sufentanil (API) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Sufentanil (API) Revenue Share by Company (2021-2026) Table 7. Global Sufentanil (API) Sales Volume by Company (k units) & (2021-2026) Table 8. Global Sufentanil (API) Sales Volume Share by Company (2021-2026) Table 9. Global Sufentanil (API) Average Price (US$/unit) of Company (2021-2026) Table 10. Global Sufentanil (API) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Sufentanil (API) Key Company Manufacturing Base & Headquarters Table 12. Global Sufentanil (API) Company, Product Type & Application Table 13. Global Sufentanil (API) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Sufentanil (API) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Purity 98% Table 18. Significant Companies of Purity 99% Table 19. Global Sufentanil (API) Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Sufentanil (API) Sales Volume by Type (2021-2026) & (k units) Table 21. Global Sufentanil (API) Sales Volume by Type (2027-2032) & (k units) Table 22. Global Sufentanil (API) Sales Volume Share by Type (2021-2026) Table 23. Global Sufentanil (API) Sales Volume Share by Type (2027-2032) Table 24. Global Sufentanil (API) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Sufentanil (API) Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Sufentanil (API) Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Sufentanil (API) Sales Value Share by Type (2021-2026) Table 28. Global Sufentanil (API) Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Injection Table 30. Significant Companies of Capsule Table 31. Global Sufentanil (API) Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Sufentanil (API) Sales Volume by Application (2021-2026) & (k units) Table 33. Global Sufentanil (API) Sales Volume by Application (2027-2032) & (k units) Table 34. Global Sufentanil (API) Sales Volume Share by Application (2021-2026) Table 35. Global Sufentanil (API) Sales Volume Share by Application (2027-2032) Table 36. Global Sufentanil (API) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Sufentanil (API) Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Sufentanil (API) Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Sufentanil (API) Sales Value Share by Application (2021-2026) Table 40. Global Sufentanil (API) Sales Value Share by Application (2027-2032) Table 41. Global Sufentanil (API) Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Sufentanil (API) Sales by Region (2021-2026) & (k units) Table 43. Global Sufentanil (API) Sales Market Share by Region (2021-2026) Table 44. Global Sufentanil (API) Sales by Region (2027-2032) & (k units) Table 45. Global Sufentanil (API) Sales Market Share by Region (2027-2032) Table 46. Global Sufentanil (API) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Sufentanil (API) Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Sufentanil (API) Sales Value Share by Region (2021-2026) Table 49. Global Sufentanil (API) Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Sufentanil (API) Sales Value Share by Region (2027-2032) Table 51. Global Sufentanil (API) Market Average Price (US$/unit) by Region (2021-2026) Table 52. Global Sufentanil (API) Market Average Price (US$/unit) by Region (2027-2032) Table 53. Global Sufentanil (API) Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Global Sufentanil (API) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Sufentanil (API) Sales by Country (2021-2026) & (k units) Table 56. Global Sufentanil (API) Sales Market Share by Country (2021-2026) Table 57. Global Sufentanil (API) Sales by Country (2027-2032) & (k units) Table 58. Global Sufentanil (API) Sales Market Share by Country (2027-2032) Table 59. Global Sufentanil (API) Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Sufentanil (API) Sales Value Market Share by Country (2021-2026) Table 61. Global Sufentanil (API) Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Sufentanil (API) Sales Value Market Share by Country (2027-2032) Table 63. Janssen Pharmaceuticals Company Information Table 64. Janssen Pharmaceuticals Business Overview Table 65. Janssen Pharmaceuticals Sufentanil (API) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Janssen Pharmaceuticals Sufentanil (API) Product Portfolio Table 67. Janssen Pharmaceuticals Recent Development Table 68. Kern Pharma Company Information Table 69. Kern Pharma Business Overview Table 70. Kern Pharma Sufentanil (API) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Kern Pharma Sufentanil (API) Product Portfolio Table 72. Kern Pharma Recent Development Table 73. Hameln Rds Company Information Table 74. Hameln Rds Business Overview Table 75. Hameln Rds Sufentanil (API) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Hameln Rds Sufentanil (API) Product Portfolio Table 77. Hameln Rds Recent Development Table 78. Cristalia Company Information Table 79. Cristalia Business Overview Table 80. Cristalia Sufentanil (API) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Cristalia Sufentanil (API) Product Portfolio Table 82. Cristalia Recent Development Table 83. Cambrex Company Information Table 84. Cambrex Business Overview Table 85. Cambrex Sufentanil (API) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Cambrex Sufentanil (API) Product Portfolio Table 87. Cambrex Recent Development Table 88. Key Raw Materials Table 89. Raw Materials Key Suppliers Table 90. Sufentanil (API) Distributors List Table 91. Sufentanil (API) Customers List Table 92. Research Programs/Design for This Report Table 93. Authors List of This Report Table 94. Secondary Sources Table 95. Primary Sources List of Figures Figure 1. Sufentanil (API) Product Image Figure 2. Global Sufentanil (API) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sufentanil (API) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Sufentanil (API) Sales (2021-2032) & (k units) Figure 5. Global Sufentanil (API) Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Sufentanil (API) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Purity 98% Image Figure 10. Purity 99% Image Figure 11. Global Sufentanil (API) Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Sufentanil (API) Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Sufentanil (API) Sales Volume Share by Type (2021-2032) Figure 14. Global Sufentanil (API) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Sufentanil (API) Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Sufentanil (API) Sales Value Share by Type (2021-2032) Figure 17. Injection Image Figure 18. Capsule Image Figure 19. Global Sufentanil (API) Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Sufentanil (API) Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Sufentanil (API) Sales Volume Share by Application (2021-2032) Figure 22. Global Sufentanil (API) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Sufentanil (API) Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Sufentanil (API) Sales Value Share by Application (2021-2032) Figure 25. Global Sufentanil (API) Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 26. Global Sufentanil (API) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Sufentanil (API) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Sufentanil (API) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Sufentanil (API) Sales Value (2021-2032) & (US$ Million) Figure 30. North America Sufentanil (API) Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Sufentanil (API) Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Sufentanil (API) Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Sufentanil (API) Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Sufentanil (API) Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Sufentanil (API) Sales Value (2021-2032) & (US$ Million) Figure 36. South America Sufentanil (API) Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Sufentanil (API) Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Sufentanil (API) Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Sufentanil (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Sufentanil (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Sufentanil (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Sufentanil (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Sufentanil (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Sufentanil (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Sufentanil (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Sufentanil (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Sufentanil (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Sufentanil (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Sufentanil (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Sufentanil (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Sufentanil (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Sufentanil (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Sufentanil (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Sufentanil (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Sufentanil (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Sufentanil (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Sufentanil (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Sufentanil (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Sufentanil (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Sufentanil (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Sufentanil (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Sufentanil (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Sufentanil (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Sufentanil (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Sufentanil (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Sufentanil (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Sufentanil (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Sufentanil (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Sufentanil (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Sufentanil (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Sufentanil (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Sufentanil (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Sufentanil (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Sufentanil (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Sufentanil (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Sufentanil (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Sufentanil (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Sufentanil (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Sufentanil (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Sufentanil (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Sufentanil (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Sufentanil (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Sufentanil (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Sufentanil (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Sufentanil (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Sufentanil (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Sufentanil (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Sufentanil (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Sufentanil (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Sufentanil (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Sufentanil (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Sufentanil (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Sufentanil (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Sufentanil (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Sufentanil (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Sufentanil (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Sufentanil (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Sufentanil (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Sufentanil (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Sufentanil (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Sufentanil (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Sufentanil (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Sufentanil (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Sufentanil (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Sufentanil (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Sufentanil (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Sufentanil (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Sufentanil (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Sufentanil (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Sufentanil (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Sufentanil (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Sufentanil (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Sufentanil (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Sufentanil (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Sufentanil (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Sufentanil (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Sufentanil (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Sufentanil (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Sufentanil (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Sufentanil (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Sufentanil (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Sufentanil (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Sufentanil (API) Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Sufentanil (API) Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Purity 98%
  • Purity 99%
Applications
  • Injection
  • Capsule
Companies covered
  • Janssen Pharmaceuticals
  • Kern Pharma
  • Hameln Rds
  • Cristalia
  • Cambrex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sufentanil (API) Sales Value (2021-2032)
  4. 1.2.2 Global Sufentanil (API) Sales Volume (2021-2032)
  5. 1.2.3 Global Sufentanil (API) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Sufentanil (API) Market Dynamics
  1. 2.1 Sufentanil (API) Industry Trends
  2. 2.2 Sufentanil (API) Industry Drivers
  3. 2.3 Sufentanil (API) Industry Opportunities and Challenges
  4. 2.4 Sufentanil (API) Industry Restraints
3 Sufentanil (API) Market by Company
  1. 3.1 Global Sufentanil (API) Company Revenue Ranking in 2025
  2. 3.2 Global Sufentanil (API) Revenue by Company (2021-2026)
  3. 3.3 Global Sufentanil (API) Sales Volume by Company (2021-2026)
  4. 3.4 Global Sufentanil (API) Average Price by Company (2021-2026)
  5. 3.5 Global Sufentanil (API) Company Ranking (2024-2026)
  6. 3.6 Global Sufentanil (API) Company Manufacturing Base and Headquarters
  7. 3.7 Global Sufentanil (API) Company Product Type and Application
  8. 3.8 Global Sufentanil (API) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Sufentanil (API) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Sufentanil (API) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Sufentanil (API) Market by Type
  1. 4.1 Sufentanil (API) Type Introduction
  2. 4.1.1 Purity 98%
  3. 4.1.2 Purity 99%
  4. 4.2 Global Sufentanil (API) Sales Volume by Type
  5. 4.2.1 Global Sufentanil (API) Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Sufentanil (API) Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Sufentanil (API) Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Sufentanil (API) Sales Value by Type
  9. 4.3.1 Global Sufentanil (API) Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Sufentanil (API) Sales Value by Type (2021-2032)
  11. 4.3.3 Global Sufentanil (API) Sales Value Share by Type (2021-2032)
5 Sufentanil (API) Market by Application
  1. 5.1 Sufentanil (API) Application Introduction
  2. 5.1.1 Injection
  3. 5.1.2 Capsule
  4. 5.2 Global Sufentanil (API) Sales Volume by Application
  5. 5.2.1 Global Sufentanil (API) Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Sufentanil (API) Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Sufentanil (API) Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Sufentanil (API) Sales Value by Application
  9. 5.3.1 Global Sufentanil (API) Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Sufentanil (API) Sales Value by Application (2021-2032)
  11. 5.3.3 Global Sufentanil (API) Sales Value Share by Application (2021-2032)
6 Sufentanil (API) Regional Sales and Value Analysis
  1. 6.1 Global Sufentanil (API) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sufentanil (API) Sales by Region (2021-2032)
  3. 6.2.1 Global Sufentanil (API) Sales by Region: 2021-2026
  4. 6.2.2 Global Sufentanil (API) Sales by Region (2027-2032)
  5. 6.3 Global Sufentanil (API) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Sufentanil (API) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Sufentanil (API) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Sufentanil (API) Sales Value by Region (2027-2032)
  9. 6.5 Global Sufentanil (API) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Sufentanil (API) Sales Value (2021-2032)
  12. 6.6.2 North America Sufentanil (API) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Sufentanil (API) Sales Value (2021-2032)
  15. 6.7.2 Europe Sufentanil (API) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Sufentanil (API) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Sufentanil (API) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Sufentanil (API) Sales Value (2021-2032)
  21. 6.9.2 South America Sufentanil (API) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Sufentanil (API) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Sufentanil (API) Sales Value Share by Country, 2025 VS 2032
7 Sufentanil (API) Country-level Sales and Value Analysis
  1. 7.1 Global Sufentanil (API) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Sufentanil (API) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Sufentanil (API) Sales by Country (2021-2032)
  4. 7.3.1 Global Sufentanil (API) Sales by Country (2021-2026)
  5. 7.3.2 Global Sufentanil (API) Sales by Country (2027-2032)
  6. 7.4 Global Sufentanil (API) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Sufentanil (API) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Sufentanil (API) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Sufentanil (API) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Sufentanil (API) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Sufentanil (API) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Sufentanil (API) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Sufentanil (API) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Sufentanil (API) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Sufentanil (API) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Sufentanil (API) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Sufentanil (API) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Sufentanil (API) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Sufentanil (API) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Sufentanil (API) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Sufentanil (API) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Sufentanil (API) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Sufentanil (API) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Sufentanil (API) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Sufentanil (API) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Sufentanil (API) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Sufentanil (API) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Sufentanil (API) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Sufentanil (API) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Sufentanil (API) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Sufentanil (API) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Sufentanil (API) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Sufentanil (API) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Sufentanil (API) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Sufentanil (API) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Sufentanil (API) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Sufentanil (API) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Sufentanil (API) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Sufentanil (API) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Sufentanil (API) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Sufentanil (API) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Sufentanil (API) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Sufentanil (API) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Sufentanil (API) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Sufentanil (API) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Sufentanil (API) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Sufentanil (API) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Sufentanil (API) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Sufentanil (API) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Sufentanil (API) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Sufentanil (API) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Sufentanil (API) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Sufentanil (API) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Sufentanil (API) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Sufentanil (API) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Sufentanil (API) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Sufentanil (API) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Sufentanil (API) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Sufentanil (API) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Sufentanil (API) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Sufentanil (API) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Sufentanil (API) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Sufentanil (API) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Sufentanil (API) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Sufentanil (API) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Sufentanil (API) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Sufentanil (API) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Sufentanil (API) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Sufentanil (API) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Sufentanil (API) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Sufentanil (API) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Sufentanil (API) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Sufentanil (API) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Sufentanil (API) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Sufentanil (API) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Sufentanil (API) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Sufentanil (API) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Sufentanil (API) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Sufentanil (API) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Sufentanil (API) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Sufentanil (API) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Sufentanil (API) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Sufentanil (API) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Sufentanil (API) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Sufentanil (API) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Sufentanil (API) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Sufentanil (API) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Sufentanil (API) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Sufentanil (API) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Sufentanil (API) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Sufentanil (API) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Sufentanil (API) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Janssen Pharmaceuticals
  2. 8.1.1 Janssen Pharmaceuticals Company Information
  3. 8.1.2 Janssen Pharmaceuticals Business Overview
  4. 8.1.3 Janssen Pharmaceuticals Sufentanil (API) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Janssen Pharmaceuticals Sufentanil (API) Product Portfolio
  6. 8.1.5 Janssen Pharmaceuticals Recent Developments
  7. 8.2 Kern Pharma
  8. 8.2.1 Kern Pharma Company Information
  9. 8.2.2 Kern Pharma Business Overview
  10. 8.2.3 Kern Pharma Sufentanil (API) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Kern Pharma Sufentanil (API) Product Portfolio
  12. 8.2.5 Kern Pharma Recent Developments
  13. 8.3 Hameln Rds
  14. 8.3.1 Hameln Rds Company Information
  15. 8.3.2 Hameln Rds Business Overview
  16. 8.3.3 Hameln Rds Sufentanil (API) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Hameln Rds Sufentanil (API) Product Portfolio
  18. 8.3.5 Hameln Rds Recent Developments
  19. 8.4 Cristalia
  20. 8.4.1 Cristalia Company Information
  21. 8.4.2 Cristalia Business Overview
  22. 8.4.3 Cristalia Sufentanil (API) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Cristalia Sufentanil (API) Product Portfolio
  24. 8.4.5 Cristalia Recent Developments
  25. 8.5 Cambrex
  26. 8.5.1 Cambrex Company Information
  27. 8.5.2 Cambrex Business Overview
  28. 8.5.3 Cambrex Sufentanil (API) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Cambrex Sufentanil (API) Product Portfolio
  30. 8.5.5 Cambrex Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sufentanil (API) Value Chain Analysis
  2. 9.1.1 Sufentanil (API) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sufentanil (API) Sales Mode & Process
  6. 9.2 Sufentanil (API) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sufentanil (API) Distributors
  9. 9.2.3 Sufentanil (API) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst